Human Cystatin-9 Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Cystatin-9 based upon sequence from: Human
Host: QP7699 protein expressed in E. coli.
Tag: His
Protein Construction: A DNA sequence encoding the Homo sapiens (Human) Cystatin-9, was expressed in the hosts and tags indicated. Please select your host/tag option, above.
Application Notes: Please contact us for application specific information for QP7699.
Bioactivity Data: Untested
Full Length? Full Length of Mature Protein
Expression Region: Trp29 – Lys159
Amino Acid Sequence: WCSEEEMGGN NKIVQDPMFL ATVEFALNTF NVQSKEEHAY RLLRVLSSWR EDSMDRKWRG KMVFSMNLQL RQTVCRKFED DIDNCPFQES LELNNVRQGI SFPQVHSCGC CMGCGVGTGA ADKAIPRDKG K
Purity: Greater than 90% as determined by SDS-PAGE.
Reconstitution Instructions:
Concentration of Human Cystatin-9 Protein:
Endotoxin Levels: Not determined.
Buffer: Tris-based buffer, 50% glycerol
Storage Conditions: Store at -20C to -80C.
Recombinant Human Cystatin-9 Protein General Information | |
---|---|
Alternate Names | |
CTES7A; CLM | |
Curated Database and Bioinformatic Data | |
Gene Symbol | CST9 |
Entrez Gene ID | 128822 |
Ensemble Gene ID | ENSG00000173335 |
RefSeq Protein Accession(s) | NP_001008693.2 |
RefSeq mRNA Accession(s) | NM_001008693.2 |
UniProt ID(s) | Q5W186 |
UniGene ID(s) | Hs.698020 |
HGNC ID(s) | HGNC:13261 |
COSMIC ID Link(s) | CST9 |
KEGG Gene ID(s) | hsa:128822 |
PharmGKB ID(s) | PA134898267 |
General Description of Recombinant Human Cystatin-9 Protein. | |
May be involved in testis development (By similarity). May play a role in hematopoietic differentiation or inflammation (PubMed:12535658). Has immunomodulatory and antimicrobial functions against Francisella tularensis, a Gram-negative bacteria (PubMed:23922243). |
Limitations and Performance Guarantee
This is a life science research product (for Research Use Only). This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.
There are no reviews yet.